文献速递肝胆胰外科

倾向性评分匹配比较机器人、腹腔镜与开腹肝切除治疗BCLC 0-A期肝癌的长期生存:前瞻性研究

A Prospective Study Using Propensity Score Matching to Compare Long-term Survival Outcomes After Robotic-assisted, Laparoscopic, or Open Liver Resection for Patients With BCLC Stage 0-A Hepatocellular Carcinoma.
PubMed 文献 · Ann Surg · 2022-01-25

该前瞻性队列研究纳入369例BCLC 0-A期肝细胞癌患者(RALR 71例、LLR 141例、OLR 157例),经倾向性评分匹配后每组56例比较。微创组(RALR+LLR)手术时间和Pringle阻断时间显著长于OLR组,但住院时间显著缩短;三组5年无病生存率(63.8%、54.4%、50.6%)和总生存率(80.8%、78.6%、75.7%)无显著差异。结论认为机器人及腹腔镜肝切除与开腹肝切除相比安全有效。

要点

  • 微创组手术时间和Pringle阻断时间显著长于OLR组,但住院时间显著缩短。
  • 三组5年无病生存率(63.8%、54.4%、50.6%)和总生存率(80.8%、78.6%、75.7%)无显著差异。
  • 临床显著门脉高压是唯一负向影响5年无病生存率的危险因素。

核心结论

  • 对于BCLC 0-A期肝细胞癌患者,机器人及腹腔镜肝切除与开腹肝切除相比安全有效。

研究设计与样本

  • 前瞻性队列研究,纳入同济医院接受治愈性肝切除的BCLC 0-A期肝细胞癌患者369例(RALR 71例、LLR 141例、OLR 157例),采用倾向性评分匹配减少选择偏倚,匹配后每组56例。

主要发现

  • 微创组(RALR+LLR)手术时间和Pringle阻断时间均显著长于OLR组,但住院时间显著缩短。
  • 三组其他术中参数和术后并发症发生率无显著差异。
  • 微创组HCC复发相比OLR组表现为单发病灶或早期HCC比例显著更高。
  • 三组5年无病生存率分别为63.8%、54.4%、50.6%,5年总生存率分别为80.8%、78.6%、75.7%,均无显著差异。
  • 临床显著门脉高压是唯一负向影响5年无病生存率的危险因素;多因素Cox回归显示临床显著门脉高压、血清甲胎蛋白≥400 ng/mL、Edmondson-Steiner分级III+IV是长期生存不良的独立危险因素。

临床怎么用

  • 对于BCLC 0-A期肝细胞癌,机器人或腹腔镜肝切除可作为开腹肝切除的替代选择,二者安全有效且长期生存无显著差异。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the short- and long-term outcomes of robot-assisted (RALR), laparoscopic (LLR), or open liver resection (OLR) in the treatment of Barcelona Clinic Liver Cancer (BCLC) stage 0-A hepatocellular carcinoma (HCC). SUMMARY BACKGROUND DATA: Following the Balliol IDEAL classification, long-term oncological outcomes can be used to evaluate the value of minimally invasive techniques in the treatment of HCC, and to assess whether they should become a standard practice. METHODS: Data from prospective cohorts of patients with BCLC stage 0-A HCC who underwent curative liver resection using OLR, LLR, or RALR at Tongji Hospital were reviewed. The short-term and long-term oncological outcomes of these 3 different surgical approaches after adequate follow-up were compared using propensity score matching to reduce selection bias. RESULTS: Of 369 patients included in this study (71, RALR; 141, LLR; and 157, OLR), 56 patients in each of the 3 groups were chosen for further comparison, after propensity score matching. In the minimally invasive group (RALR+LLR), both the operative time and duration of Pringle's maneuver were significantly longer than those in the OLR group; however, the length of hospital stay was significantly shorter. There were no significant differences in the other intraoperative parameters and the incidence of postoperative complications among the 3 groups. HCC recurrence in the minimally invasive group when compared with the OLR group was characterized by a significantly higher proportion of single lesion or early-stage HCC. However, there were no significant differences in the 5-year disease-free survival (63.8%, 54.4%, and 50.6%) or overall survival rates (80.8%, 78.6%, and 75.7%, respectively) among the 3 groups. Clinically significant portal hypertension was the only risk factor that negatively affected the 5-year disease-free survival rate. Multivariate Cox regression analysis showed that clinically significant portal hypertension, serum alpha-fetoprotein level (≥400 ng/mL), and Edmondson-Steiner grading (III+IV) were independent risk factors for poor long-term survival. CONCLUSION: Both robotic and laparoscopic hepatectomies were safe and effective for patients with BCLC stage 0-A HCC when compared with open hepatectomy.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Zhu P, Liao W, Zhang WG, et al. A Prospective Study Using Propensity Score Matching to Compare Long-term Survival Outcomes After Robotic-assisted, Laparoscopic, or Open Liver Resection for Patients With BCLC Stage 0-A Hepatocellular Carcinoma. Ann Surg. 2022. PMID: 35081573. doi:10.1097/SLA.0000000000005380

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。